ClinicalTrials.gg
RecruitingNCT06808269ChirépauleUpdated Oct 5, 2026

Prospective Comparative Multicenter Study of the Care Pathway After Shoulder Surgery

An interventional study of Vivalto Dom follow-up and Liberal follow-up in Shoulder Injury, sponsored by Clinique Victor Hugo. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Clinique Victor Hugo · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.
Updated Oct 5, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Shoulder Injuries with a site in France — 2 open to participants now, 3 under way, none of them phase 3. Shoulder Injuries · France.

Started
2025
with 2 others
No phase
6 of 10
2 open now
Registered
8th of 10
by date
Lead sponsor
1 of 10
Clinique Victor Hugo

Among the 10 studies in Shoulder Injuries with a site in France, this one is one of 3 that started in 2025, is one of 6 with no phase, and was the 8th registered.

Shoulder Injuries

118 studies on the registry are indexed under Shoulder Injuries; 32 are open to participants now.

Browse Shoulder Injuries studies →

Open to participants now

2 of the 10 studies in Shoulder Injuries with a site in France are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 17 Shoulder Injuries studies recruiting now, 8 (47%) set no upper age limit and 6 (35%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Shoulder Injuries with a site in France, or all of them as a file.
02

Study summary

Post-operative management of shoulder surgery patients, particularly in terms of pain management and follow-up, can vary from one center to another, influencing clinical outcomes and patient satisfaction. The aim of this study is to compare two approaches to post-operative follow-up in two distinct centers: structured follow-up using the Vivalto-Dom protocol in Paris, and autonomous follow-up through contact with a nurse in Saint-Grégoire. The hypothesis is that these differences in the care pathway will affect pain management, comfort and patient satisfaction. By controlling for operative variability (a single surgeon operating in both centers), the study will identify the most effective follow-up practices for improving post-operative management, with the ultimate aim of optimizing quality of care and reducing post-operative complications.

03

Conditions studied

  • Shoulder Injury

Keywords

  • shoulder surgery
  • pain
  • comfort
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient eligible for one of the following 4 types of surgery: Simple non-repair arthroscopic surgery (acromion, calcification), arthroscopic repair surgery (cuff, DAS, bankart), open surgery without prosthesis (ligamentoplasty, bone block), open surgery with prosthesis (inverted prosthesis, anatomic prosthesis, etc.).

Exclusion criteria

Exclusion Criteria:

  • Patients with one or more communication disorders.
  • Pregnant or breast-feeding patients
  • Patients not covered by a social security scheme
  • Refusal to participate in research
  • Patients unable to understand or give
  • Patients under guardianship, deprived of liberty or under court protection
  • Patients with past or present drug addiction
  • Patients with neuropathy
  • Patients with cognitive disorders
  • Patients with chronic illnesses or inflammatory pathologies leading to chronic pain.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
210 participants (estimated)

Study arms

  • Experimental
    structured follow-up after surgery

    Procedure: Vivalto Dom follow-up

  • Active comparator
    liberal follow-up after surgery

    Procedure: Liberal follow-up

Interventions

  • ProcedureVivalto Dom follow-up

    During the pre-operative consultation, the patient receives a prescription for medication (analgesics and anti-inflammatories) for immediate post-operative pain relief. They also receive a "patient information booklet" (see appendix 6). On discharge from surgery, the patient returns home with Vivalto Dom in charge of nursing care and follow-up medication. Vivalto Dom is a homecare structure whose mission is to coordinate the discharge of patients back home, and to ensure continuity of overall care (care and social aspects) between the hospital and the city.

  • ProcedureLiberal follow-up

    The pre-operative and operative course (fasting rules, skin preparation, hospitalization, surgery) is the same as for all routine care patients. The patient is informed before surgery that he or she must make an appointment with a nurse for post-operative care at home; a prescription for medication (analgesics and anti-inflammatories) has been given by the anaesthetist for immediate analgesic treatment, and on discharge from hospital he or she receives another prescription from the surgeon for oral relay treatment. Follow-up at home takes place over 3 days, with a private nurse visiting the patient's home every day. During the follow-up, the nurse performs clinical monitoring of the following items: pulse, blood pressure, temperature, pain, bleeding, monitoring of the surgical wound, transit, nausea and vomiting. The patient is also guided through the medication protocol.

06

What researchers measure

Primary outcomes

  1. Pain intensity (VAS)

    Pain will be measured using VAS (visual analog scale), from 0 ("no pain") to 10 (maximal pain)

    Time frame: 3 days, 6 weeks, 3 months and 6 months after surgery

Secondary outcomes

  1. Patient comfort (Likert scale)

    Patient comfort will be evaluated using a Likert scale for 6 questions. Scale is from 1 (total discomfort) to 5 (total comfort)

    Time frame: 3 days, 6 weeks, 3 months and 6 months after surgery

  2. Postoperative complications

    Time frame: 3 days, 6 weeks, 3 months and 6 months after surgery

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Jun 2028, 37 months after the start.

Of 38 non-industry interventional studies with no phase under Shoulder Injuries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 45. This study's planned 37 months is above that.

Counting every sponsor, half of 43 studies reached it within 15 months; a quarter within 7 and three quarters within 45.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 5, 2026: primary completion Jun 2026 → Jun 2028 and completion Aug 2026 → Aug 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 28, 2025
First posted
Feb 5, 2025
StartActual
May 19, 2025
Primary completionEst.
Jun 30, 2028was Jun 2026
CompletionEst.
Aug 31, 2028was Aug 2026
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jun 30, 2026→Jun 30, 2028
Oct 5, 2026
Study completion
Aug 31, 2026→Aug 31, 2028
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    Primary completion Jun 30, 2026→Jun 30, 2028
    Study completion Aug 31, 2026→Aug 31, 2028
    + 2 other changes: identifiers and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06808269
Lead sponsor
Clinique Victor Hugo
Responsible party
Sponsor
First posted
Feb 5, 2025
Start date
May 19, 2025
Primary completion
Jun 30, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Oct 5, 2026

Study contacts

Philippe Collin, MD
Contact
docphcollin@gmail.com
+33 6 08 91 47 47

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion